this title and has been placed on any schedule other than 
schedule I or II or has been removed from the controlled 
substance schedules, the sentencing court may, on motion 
of the defendant, the Bureau of Prisons, the attorney for 
the Government, or on its own motion, after considering 
the factors set forth in section 3553(a) of title 18, United 
States Code, vacate the previously imposed sentence, or 
impose a reduced sentence on any count of conviction as 
if the removal or placement was in effect at the time that 
the offense was committed. Nothing in this section may 
be construed to require a court to vacate or reduce any 
sentence.’’. 
SEC. 7. REGISTRATION REQUIREMENTS RELATED TO RE-
SEARCH. 
(a) ALTERNATIVE
REGISTRATION
PROCESS
FOR 
SCHEDULE I RESEARCH.—Section 303 of the Controlled 
Substances Act (21 U.S.C. 823) is amended by adding at 
the end the following new subsection: 
‘‘(l) SPECIAL PROVISIONS FOR THOSE CONDUCTING 
CERTAIN RESEARCH WITH SCHEDULE I CONTROLLED 
SUBSTANCES.— 
‘‘(1) IN GENERAL.—Notwithstanding subsection 
(f), a practitioner may conduct research that is de-
scribed in paragraph (2) and that is with one or 
VerDate Sep 11 2014 
20:31 Mar 09, 2022
Jkt 029200
PO 00000
Frm 00016
Fmt 6652
Sfmt 6201
E:\BILLS\H6946.IH
H6946
pamtmann on DSKBC07HB2PROD with BILLS
more controlled substances in schedule I if one of 
the following conditions is satisfied: 
‘‘(A) RESEARCHER
WITH
A
CURRENT 
SCHEDULE I OR II RESEARCH REGISTRATION.— 
If the practitioner is registered to conduct re-
search with a controlled substance in schedule 
I or II, the practitioner may conduct research 
under this paragraph 30 days after the practi-
tioner has sent a notice to the Attorney General 
containing the following information, with re-
spect to each substance with which the research 
will be conducted: 
‘‘(i) The chemical name of the sub-
stance. 
‘‘(ii) The quantity of the substance to 
be used in such research. 
‘‘(iii) Demonstration that the research 
is described in paragraph (2), which dem-
onstration can be satisfied— 
‘‘(I) in the case of research de-
scribed in paragraph (2)(A), by sup-
plying the number of the application 
submitted under section 505(i) of the 
Federal Food, Drug, and Cosmetic 
Act or section 351(a)(3) of the Public 
VerDate Sep 11 2014 
20:31 Mar 09, 2022
Jkt 029200
PO 00000
Frm 00017
Fmt 6652
Sfmt 6201
E:\BILLS\H6946.IH
H6946
pamtmann on DSKBC07HB2PROD with BILLS
Health Service Act and the sponsor of 
record on such application; or 
‘‘(II) in the case of research de-
scribed in paragraph (2)(B), by iden-
tifying the sponsoring agency and 
supplying the number of the grant, 
contract, cooperative agreement, other 
transaction, or project. 
‘‘(iv) Demonstration that the re-
searcher is authorized to conduct research 
with respect to the substance under the 
laws of the State in which the research will 
take place. 
‘‘(B) RESEARCHER WITHOUT A CURRENT 
SCHEDULE I OR II RESEARCH REGISTRATION.— 
If the practitioner is not currently registered to 
conduct research with a controlled substance in 
schedule I or II— 
‘‘(i) the practitioner may send a no-
tice to the Attorney General containing the 
information listed in subparagraph (A), 
with respect to each substance with which 
the research will be conducted; 
VerDate Sep 11 2014 
20:31 Mar 09, 2022
Jkt 029200
PO 00000
Frm 00018
Fmt 6652
Sfmt 6201
E:\BILLS\H6946.IH
H6946
pamtmann on DSKBC07HB2PROD with BILLS
‘‘(ii) the Attorney General shall treat 
such notice as a sufficient application for 
a research registration; and 
‘‘(iii) within 45 days after receiving 
such a notice that contains all information 
required by subparagraph (A), the Attor-
ney General shall register the applicant, or 
serve an order to show cause upon the ap-
plicant in accordance with section 304(c). 
‘‘(C) VERIFICATION
OF
INFORMATION.— 
On request from the Attorney General, the Sec-
retary of Health and Human Services or the 
Secretary of Veterans Affairs, as appropriate, 
shall verify information submitted by an appli-
cant under subparagraph (A)(iii). 
‘‘(2) RESEARCH SUBJECT TO EXPEDITED PRO-
CEDURE.—Research described in this paragraph is 
research that— 
‘‘(A) is the subject of an application under 
section 505(i) of the Federal Food, Drug, and 
Cosmetic Act or section 351(a)(3) of the Public 
Health Service Act for the investigation of a 
drug which is in effect in accordance with sec-
tion 312.40 of title 21, Code of Federal Regula-
tions; or 
VerDate Sep 11 2014 
20:31 Mar 09, 2022
Jkt 029200
PO 00000
Frm 00019
Fmt 6652
Sfmt 6201
E:\BILLS\H6946.IH
H6946
pamtmann on DSKBC07HB2PROD with BILLS